ArticleThe Journal of clinical investigation2018

Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes.

Natalia Rodriguez-Muela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.